Angle PLC Announces Parsortix Used in Research Paper from ETH Zurich

January 24, 2025 5:05 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted to announce the publication of breakthrough research from Professor Nicola Aceto's team at the research university ETH Zurich, Switzerland, in the journal Nature Medicine.The publication reports on an interventional multi-centre Phase 1 clinical...

Read more

Global Sphingolipids Market to Reach USD 1,145.6 Million by 2035, Driven by Advancements in Health and Nutritional Applications | Future Market Insights, Inc.

January 24, 2025 1:30 AM

The global sphingolipids market, valued at approximately USD 693.9 million in 2025, is set to exhibit robust growth with a CAGR of 5.1% during the forecast period. By 2035, the market is projected to reach an estimated valuation of USD 1,145.6 million, according to industry analysis.The physiological and functional advantages of sphingolipids, which are essential parts of eukaryotic organisms, have drawn more and more attention. These lipid...

Read more

The Middle East's Rapid Ascent in Digital Health Innovation: A Global Benchmark in the 2025 Black Book

January 23, 2025 5:30 PM

The Middle East is undergoing a seismic transformation in healthcare IT, emerging as one of the fastest-growing regions for digital health innovation. According to the 2025 Black Book of Global Healthcare IT, the region's rapid advancements in electronic health records (EHR), artificial intelligence (AI), interoperability, and revenue cycle management (RCM) reflect a bold commitment to redefining healthcare for the 21st century.This year's Black...

Read more

Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules

January 23, 2025 4:15 PM

SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the closing of its previously announced private placement for the issuance and sale of an aggregate of 2,007,880 shares of common stock (or pre-funded warrants in lieu thereof)...

Read more

Formula Wellness Formally Announces Amar K. Thakrar, PharmD, MBA, as Chief Operating Officer

January 23, 2025 4:00 PM

Formula Wellness, a premier provider of integrated aesthetics and wellness services, is proud to formally announce Amar K. Thakrar, PharmD, MBA, as its Chief Operating Officer. This announcement reflects the company's ongoing commitment to operational excellence and patient-centered care under his leadership.With nearly a year of service in this role, Dr. Thakrar has been instrumental in refining operational strategies and advancing Formula...

Read more

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

January 23, 2025 3:35 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered into a supplemental exclusive distribution agreement with Virax Biolabs Group Limited (NASDAQ:VRAX)...

Read more

The National Children's Cancer Society (NCCS) Introduces New Signature Fundraising Event

January 23, 2025 3:30 PM

The National Children's Cancer Society (NCCS) is excited to announce its newest signature fundraising event, An Evening with the Blues! Scheduled for Saturday, May 10, 2025, at the historic St. Louis Union Station Hotel, An Evening with the Blues will bring together hockey fans, community members, and supporters for a night of unforgettable entertainment. The event will feature National Hockey League Hall of Fame legends Brett Hull and Chris...

Read more

Healthcare IT Faces Disruption and Innovation Challenges as GOP Budget Cuts Loom: Insights From Black Book Weekly Survey

January 23, 2025 11:30 AM

Proposed federal healthcare budget cuts, aimed at achieving over $3 trillion in savings, are poised to create significant disruptions within the healthcare IT sector. Recent federal actions, including an executive order to withdraw from the World Health Organization (WHO) and the rollback of drug pricing reforms, have compounded challenges for healthcare providers and IT vendors. These findings are part of an in-depth Q1 2025 Black Book Research...

Read more

US Med-Equip and Zopec Medical Partner to Help Hospitals with Back-up Battery Power for Life-Saving Medical Equipment

January 23, 2025 11:00 AM

US Med-Equip (USME) the nation's highest-rated provider of medical equipment rentals, sales, biomedical support and asset management service, teamed up with Zopec Medical to help hospitals power life-saving medical equipment.Zopec Medical's batteries are known for their portability, high performance and compatibility with multiple medical devices. Unlike traditional battery backups, their solutions are lightweight, long-lasting and designed for...

Read more

New Research Highlights Cognitive Improvements Achieved With At-Home Brain Balance Program

January 23, 2025 9:00 AM

Brain Balance, a brain-based program that addresses behavioral, social, and academic struggles using evidence-based methods to optimize brain health and development without medication, has published the findings of its recent study, Cognitive Outcomes of the At-Home Brain Balance Program. The study, published in the prominent journal Frontiers in Child and Adolescent Psychiatry, highlights the transformative potential of a home-based Brain...

Read more

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

January 23, 2025 7:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2024 financial results after market close on Wednesday, February 19, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.Conference Call...

Read more

Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies

January 23, 2025 5:30 AM

Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical and transdermal pharmaceutical research and development company, with proprietary Invisicare® drug delivery technology, today announces significant achievements in 2024 and 2025, through its licensee Quoin Pharmaceuticals' progress in Netherton Syndrome treatment.Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology...

Read more

Oubaitori Psychotherapy Launches Telehealth Offerings for Life Transitions, PTSD, Anxiety and Trauma Support in the USA

January 23, 2025 3:35 AM

Oubaitori Psychotherapy is a fully virtual psychotherapy business led by Licensed Clinical Social Worker Shelby DeBord, is excited to announce the launch of its telehealth therapy services for residents in California, Nevada, and Texas. With a focus on providing tailored therapy for individuals navigating life transitions, PTSD/Complex Trauma and De-stigmatizing BPD. The concept of Oubaitori Psychotherapy emphasizes the concept of the individual...

Read more

Angle PLC Announces Trading Update

January 23, 2025 2:30 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to provide a trading update in relation to full year 2024 financial results.Revenues for the year ended 31 December 2024 are expected to be up 31% at £2.9 million (FY23: £2.2 million).The cash position of the Company remains solid, and stronger than...

Read more

IRLAB has Received a Waiver from the EMA Regarding Pediatric Studies with Mesdopetam in Parkinson's Disease

January 23, 2025 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 23, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that a waiver regarding pediatric studies of mestopetam has been granted by the European Medicines Agency (EMA), which means that IRLAB does not have to perform studies of mesdopetam in children. The waiver enables IRLAB...

Read more

Dr. Ahmet Ergin Announces New Practice: Diabetes, Thyroid & Hormone Center of the Treasure Coast

January 23, 2025 12:20 AM

Dr. Ahmet Ergin is excited to announce the launch of his new practice, Diabetes, Thyroid & Hormone Center of the Treasure Coast, beginning February 3, 2025. Patients can rest assured that Dr. Ergin will remain in the same office location and continue using the same phone number, ensuring a seamless transition and uninterrupted care. Dr. Ergin has built a reputation as a trusted expert in diabetes, thyroid, and hormone health. His new practice...

Read more

Onco-Innovations Enters into LOI with Inka Health to Implement AI Technology Toward Cancer Detection and Drug Development

January 22, 2025 6:00 PM

Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)("Onco" or the "Company") is pleased to announce that it has entered into a letter of intent (the "LOI") with Inka Health Corp. ("Inka Health"), an arms-length party holding a state-of-the-art proprietary artificial intelligence platform ("Inka Platform"). Through this potential acquisition, the Company aims to leverage Inka Health's cutting-edge SynoGraph™ technology, a...

Read more

Netsmart Maintains Leadership in EHR/PM Satisfaction Among Behavioral Health Providers in 2025 Black Book Survey

January 22, 2025 4:30 PM

Netsmart has once again been recognized as the top-rated provider of Electronic Health Record (EHR) and Practice Management (PM) solutions for Behavioral Health, according to Black Book Research's 2025 client satisfaction survey. The extensive survey, conducted from August 2024 to January 2025, underscores Netsmart's exceptional performance across key functional areas, including revenue cycle management, clinical documentation, and patient...

Read more

Driving Innovation Through Diversity, Equity, and Inclusion: Insights From Black Book Research's 2025 Study on Healthcare IT

January 22, 2025 11:45 AM

Black Book Research's latest 2025 study, Innovation for Equity: The Transformative Role of DEI in Healthcare IT Success, underscores the critical importance of Diversity, Equity, and Inclusion (DEI) initiatives in driving innovation, operational excellence, and social accountability within the healthcare IT sector. The report emphasizes that embedding DEI principles into technology, leadership, and organizational culture is no longer optional...

Read more

CMS Doubles Down on Medicare Drug Price Controls, Threatening Patient Access and Innovation

January 22, 2025 11:45 AM

The Centers for Medicare & Medicaid Services (CMS) has announced an additional 15 drugs that will be subject to price controls under the Inflation Reduction Act (IRA). This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions."The...

Read more